Study of Prasugrel in Korean Healthy Male Volunteers

Phase 1 Completed 30 enrolled Eli Lilly and Company

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate how the body processes prasugrel and how prasugrel affects blood clotting in healthy Korean men. Three different dosing regimens of prasugrel will be given. Information on side effects will also be collected.

Timeline

Start: 2009-03
Primary completion: 2009-05
Completion: 2009-05

Publications

Yu KS, Park KW, Kelly RP, Gu N, Payne C, Small DS, Choi HC, Kawakatsu E, Pinton P. Pharmacokinetic and pharmacodynamic effects of prasugrel in healthy Korean males. J Cardiovasc Pharmacol. 2013 Jul;62(1):72-7. doi: 10.1097/FJC.0b013e318290d9e1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Prasugrel	Small molecule	5 mg	Oral
Subject	Prasugrel	Small molecule	7.5 mg	Oral
Subject	Prasugrel	Small molecule	10 mg	Oral

Indications

No indication recorded.